We use cookies to improve your experience. By your continued use of this site you accept such use. To change your settings please see our Privacy Policy.
I accept

08 Nov. 2022

Preventive Voluntary Recall for Ectrin Capsule 300mg (Update)

MORE

25 Oct. 2022

Orient EuroPharma Introduces Novel injectable treatments Manufactured by Chiesi for the Treatment of Rare Diseases, Offering New Therapeutic Options of Enzyme Replacement Therapy to Patients in Taiwan and Southeast Asia Markets

MORE

22 Sep. 2022

Taiwan Is Facing Obesity Crisis; the Latest Mechanistically Modified Oral Obesity Drug Is Available for Prescription

MORE

04 Aug. 2022

Cumlaude Lab, the Spain Leading Women Intimate Care Products Are Now Availabe in Taiwan

MORE

12 Jul. 2022

OEP Enters into a Strategic Partnership with Overland ADCT BioPharma to Address the Unmet Needs of Lymphoma Patients in Taiwan and Singapore

MORE

09 May. 2022

OEP introduces the latest long-acting injection approved for the treatment of schizophrenia in Europe and acquires Taiwan and Hong Kong distribution rights to expand psychiatry product portfolio

MORE

07 Mar. 2022

New hypolipidemic compound drug enters South Korea. Orient Pharma alliance with KUHNIL PHARMA to explore new markets

MORE

11 Feb. 2022

OEP’s Cytotoxic Oncology Injection Plant Receives TFDA PIC/S GMP Certification

MORE

28 Oct. 2021

Karihome, the leading goat milk powder brand, celebrates its 30th anniversary with two generations of lovers sharing the benefits of goat milk with its endorser.

MORE

26 Oct. 2021

OEP's new drug for resistant hypertension enters phase III clinical trial. Ten hospitals in Taiwan to start enrolling cases in November

MORE